XML 119 R11.htm IDEA: XBRL DOCUMENT v2.4.0.6
Financial Instruments Owned, at Fair Value and Financial Instruments Sold, But Not Yet Purchased, at Fair Value
12 Months Ended
Dec. 31, 2012
Financial Instruments Owned, at Fair Value and Financial Instruments Sold, But Not Yet Purchased, at Fair Value [Abstract]  
Financial Instruments Owned, at Fair Value and Financial Instruments Sold, But Not Yet Purchased, at Fair Value
Note 4. Financial Instruments Owned, at Fair Value and Financial Instruments Sold, But Not Yet Purchased, at Fair Value

Note 4.

 

Financial Instruments Owned, at Fair Value and Financial Instruments Sold, But Not Yet Purchased, at Fair Value

       

 

Financial instruments owned, at fair value and financial instruments sold, but not yet purchased, at fair value are accounted for at fair value either under the fair value option or in accordance with other U.S. GAAP. See Note 8 for further information about the fair value option. The table below presents the firm’s financial instruments owned, at fair value, including those pledged as collateral, and financial instruments sold, but not yet purchased, at fair value. The firm held $9.07 billion and $4.86 billion as of December 2012 and December 2011, respectively, of securities accounted for as available-for-sale related to the firm’s reinsurance business. As of December 2012, such assets were classified as held for sale and were included in “Other assets.” See Note 12 for further information about assets held for sale. As of December 2011, all available-for-sale securities were included in “Financial instruments owned, at fair value.”

 

 

                                     
    As of December 2012         As of December 2011  
in millions    
 
 
Financial
Instruments
Owned
  
  
  
   
 
 
 
 
Financial
Instruments
Sold, But
Not Yet
Purchased
  
  
  
  
  
       
 
 
Financial
Instruments
Owned
  
  
  
   
 
 
 
 
Financial
Instruments
Sold, But
Not Yet
Purchased
  
  
  
  
  

Commercial paper, certificates of deposit, time deposits and other
money market instruments

    $    6,057       $         —           $  13,440       $         —  
   

U.S. government and federal agency obligations

    93,241       15,905           87,040       21,006  
   

Non-U.S. government and agency obligations

    62,250       32,361           49,205       34,886  
   

Mortgage and other asset-backed loans and securities:

                                   

Loans and securities backed by commercial real estate

    9,805                 6,699       27  
   

Loans and securities backed by residential real estate

    8,216       4           7,592       3  
   

Bank loans and bridge loans

    22,407       1,779  3          19,745       2,756  3 
   

Corporate debt securities

    20,981       5,761           22,131       6,553  
   

State and municipal obligations

    2,477       1           3,089       3  
   

Other debt obligations

    2,251                 4,362        
   

Equities and convertible debentures

    96,454       20,406           65,113       21,326  
   

Commodities 1

    11,696                 5,762        
   

Derivatives 2

    71,176       50,427           80,028       58,453  

Total

    $407,011       $126,644           $364,206       $145,013  

 

1.

Includes commodities that have been transferred to third parties, which were accounted for as collateralized financings rather than sales, of $4.29 billion and $2.49 billion as of December 2012 and December 2011, respectively.

 

2.

Net of cash collateral received or posted under credit support agreements and reported on a net-by-counterparty basis when a legal right of setoff exists under an enforceable netting agreement.

 

3.

Primarily relates to the fair value of unfunded lending commitments for which the fair value option was elected.

 

Gains and Losses from Market Making and Other Principal Transactions

The table below presents, by major product type, the firm’s “Market making” and “Other principal transactions” revenues. These gains/(losses) are primarily related to the firm’s financial instruments owned, at fair value and financial instruments sold, but not yet purchased, at fair value, including both derivative and non-derivative financial instruments. These gains/(losses) exclude related interest income and interest expense. See Note 23 for further information about interest income and interest expense.

The gains/(losses) in the table are not representative of the manner in which the firm manages its business activities because many of the firm’s market-making, client facilitation, and investing and lending strategies utilize financial instruments across various product types. Accordingly, gains or losses in one product type frequently offset gains or losses in other product types. For example, most of the firm’s longer-term derivatives are sensitive to changes in interest rates and may be economically hedged with interest rate swaps. Similarly, a significant portion of the firm’s cash instruments and derivatives has exposure to foreign currencies and may be economically hedged with foreign currency contracts.

 

 

                         
    Year Ended December  
in millions     2012       2011       2010  

Interest rates

    $  4,366       $  1,557       $ (2,042
   

Credit

    5,506       2,715       8,679  
   

Currencies

    (1,004     901       3,219  
   

Equities

    5,802       2,788       6,862  
   

Commodities

    575       1,588       1,567  
   

Other

    1,968  1      1,245       2,325  

Total

    $17,213       $10,794       $20,610  

 

1.

Includes a gain of approximately $500 million on the sale of the firm’s hedge fund administration business, which is included in “Market making” revenues.